by Bioactive peptides play a vital role for various health benefits in the human body. They prevent hypertension, improve digestive health, and boost immunity. With evolving lifestyle patterns, consumers are shifting to functional food and beverages that provide additional health advantages. Bioactive peptides help manufacturers develop fortified products that offer relief from lifestyle diseases.
The global Bioactive Peptide Market is estimated to be valued at US$ 11.29 Bn in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Consumers are spending more on ready-to-eat food products fortified with protein, vitamins, and other nutrients. Leading companies are introducing new product lines infused with bioactive peptides to improve bone health, brain function, cardiac function, immunity, and weight management. With rising health consciousness, the demand for bioactive enriched food and drinks is increasing significantly. This trend is expected to continue during the forecast period, thereby accelerating the growth of the global bioactive peptide market.
Segment Analysis
The global bioactive peptide market is segmented into protein source and application. On the basis of protein source, the whey protein-derived peptides hold a dominant market share as these are low-cost raw materials with numerous health benefits. Due to increasing awareness regarding the various advantages of whey protein including muscle building, immune function, and cardiovascular health among others, the demand for whey protein peptides is high.
Key Takeaways
The Global Bioactive Peptide Market Size is expected to witness high growth over the forecast period. Factors such as rising consumer awareness about various health benefits offered by bioactive peptides along with initiatives by various government bodies and food safety organizations will drive the demand for bioactive peptides.
Regional analysis shows that North America is currently dominating the global bioactive peptide market owing to increased health-consciousness among consumers, advancements in biotechnology, and presence of major players in the region. However, Asia Pacific is projected to grow at the fastest rate attributed to rising disposable incomes, growing expenditure on nutrition and health supplements, and rapid urbanization.
Key players operating in the bioactive peptide market are Archer Daniels Midland Company, Kerry Group, Cargill, Incorporated, DSM, Darling Ingredients Inc., ETChem, FrieslandCampina, Arla Foods, and Roquette Frères. Amongst these, Archer Daniels Midland Company is the global leader with the widest product portfolio. Other major players are focusing on new product launches, acquisitions and facility expansion to strengthen their market presence.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
